Scott Moore explores China’s trajectory in the global biotechnology sector. Whilst America has become the dominant international player in building and commercializing biotechnology for many years, China is set to become a number one participant in biotechnology and is particularly investing intensely during the sector. Moore argues that, whilst … Read More